Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pomalidomide monotherapy in refractory/relapsed multiple myeloma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2015-07-30